The Sphingosine 1-Phosphate Receptor Modulator Fingolimod as a Therapeutic Agent: Recent Findings and New Perspectives

Pharmacology and Therapeutics - United Kingdom
doi 10.1016/j.pharmthera.2017.11.001
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Elsevier BV

Related search

Purification and Identification of Activating Enzymes of CS-0777, a Selective Sphingosine 1-Phosphate Receptor 1 Modulator, in Erythrocytes

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2011English

Effects of High- And Low-Fat Meals on the Pharmacokinetics of Ozanimod, a Novel Sphingosine-1-Phosphate Receptor Modulator

Clinical Pharmacology in Drug Development
PharmacologyPharmaceutical Science
2017English

Sphingosine 1-Phosphate Receptor 1 (S1PR1; S1P1; EDG1)

Science-Business eXchange
2014English

FTY720 (Fingolimod) Efficacy in an Animal Model of Multiple Sclerosis Requires Astrocyte Sphingosine 1-Phosphate Receptor 1 (S1P1) Modulation

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

Sphingosine 1-Phosphate as a Therapeutic Target in Heart Failure: More Questions Than Answers

Circulation
Cardiovascular MedicinePhysiologyCardiology
2012English

Activation Mechanisms of the First Sphingosine-1-Phosphate Receptor

Protein Science
BiochemistryMedicineMolecular Biology
2017English

Sphingosine-1–phosphate Receptor 2 (S1PR2; S1P2; EDG5)

Science-Business eXchange
2010English

Sphingosine 1-Phosphate Receptor 2 (S1PR2; S1P2; EDG5)

Science-Business eXchange
2013English

Recent Advances on Toll-Like Receptor 4 Modulation: New Therapeutic Perspectives

Future Medicinal Chemistry
Drug DiscoveryMolecular MedicinePharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy